Total Funding
90
64
Total FundingFunding Round raised
Growth Score
-3 pts
Heat Score
-21 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
62770
Ribocure Pharmaceuticals is a biotech company specializing in the development of RNA-based and oligonucleotide therapeutics.
- Li-Ming Gan: CEO & Co-Founder
About the Company
Ribocure Pharmaceuticals AB is a biotechnology company that focuses on the development of RNA-based therapeutics. The company's primary area of expertise lies in oligonucleotide therapeutics, a type of RNA-based treatment. Ribocure's team is dedicated to drug discovery in this field. The company also has a clinical trial unit, indicating
its active involvement in research and development. Ribocure's business operations also include global business development, led by a Vice President and Head of Global Business Development.
